Volume | 195,131 |
|
|||||
News | (2) | ||||||
Day High | 15.37 | Low High |
|||||
Day Low | 15.18 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
BlackRock Health Sciences Term Trust | BMEZ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
15.21 | 15.18 | 15.37 | 15.27 | 15.15 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
956 | 195,131 | US$ 15.27 | US$ 2,978,823 | - | 12.93 - 16.63 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 400 | US$ 15.27 | USD |
BlackRock Health Sciences Term Trust Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
203.6M | 13.33M | - | 13.15M | 69.86M | 5.24 | 2.91 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BlackRock Health Science... News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMEZ Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.13 | 15.37 | 14.92 | 15.10 | 289,193 | 0.14 | 0.93% |
1 Month | 15.00 | 15.69 | 14.92 | 15.21 | 271,122 | 0.27 | 1.80% |
3 Months | 16.43 | 16.55 | 14.38 | 15.48 | 259,109 | -1.16 | -7.06% |
6 Months | 13.82 | 16.59 | 13.82 | 15.17 | 394,790 | 1.45 | 10.49% |
1 Year | 15.72 | 16.63 | 12.93 | 14.93 | 383,787 | -0.45 | -2.86% |
3 Years | 28.49 | 29.99 | 12.93 | 17.05 | 337,753 | -13.22 | -46.40% |
5 Years | 20.08 | 30.96 | 12.60 | 18.67 | 314,551 | -4.81 | -23.95% |
BlackRock Health Science... Description
BlackRock Health Sciences Trust IIs (BMEZ) (the Trust) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80 Percent of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trusts risk-adjusted returns. |